Helicobacter pylori resistance to metronidazole and to clarithromycin in Spain. A systematic review;Resistencia de Helicobacter pylori al metronidazol y a la claritromicina en España. Una revisión sistemática

Medicina Clinica

Volumn 116, Issue 3, 2001, Pages 111-116

  Gisbert, J P ^a   Pajares, J M ^a  

^a Playa de Mojacar   (Spain)

Author keywords

Clarithromycin; Culture; Diagnosis; Helicobacter pylori; Metronidazole; Nitroimidazole; Resistance; Tinidazole

Indexed keywords

CLARITHROMYCIN; METRONIDAZOLE;

ANTIBIOTIC RESISTANCE; DRUG EFFICACY; ERADICATION THERAPY; GASTRODUODENAL ULCER; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; REVIEW; SPAIN; STOMACH ADENOCARCINOMA;

EID: 0000843139     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(01)71738-1     Document Type: Review

References (71)

1. ¿Son todos los H. pylori malos?
2. Helicobacter pylori y úlcera duodenal: ¿relación causal o mera asociación?
3. Epidemiology and mechanisms of antibiotic resistance in Helicobacter pylori
4. Resistance of Helicobacter pylori to antibiotics: The main limitation of current proton-pump inhibitor tripe therapy
5. Antibiotic susceptibility of H. pylori in Europe in 1998; results of the third multicentre study
6. Susceptibility of Helicobacter pylori to metronidazole
7. Efecto de la «triple terapia» sobre la erradicación de Helicobacter pylori y la cicatrización de la úlcera duodenal. Estudio inicial y a los 6 meses
8. ¿De qué factores depende el éxito de la triple terapia «clásica» en la erradicación de Helicobacter pylori?
9. Evolution of resistance of metronidazole and clarithromycin in Helicobacter pylori clinical isolates from Spain
10. Erradicación mediante triple terapia de Helicobacter pylori en pacientes ulcerosos: Papel de la endoscopia y sensibilidad anbitiótica
11. Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing
12. Diagnóstico microbiológico de Helicobacter pylori y su resistencia a los antimicrobianos
13. Resistencia antibiótica de H. pylori en Sevilla
14. Evolución de las resistencias primarias de Helicobacter pylori
15. Análisis de la resistencia de Helicobacter pylori a antibióticos en nuestro medío
16. How long for the routine Helicobacter pylori antimicrobial susceptibility testing? The usefulness of the string test to obtain Helicobacter for culture
17. Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: A prospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer
18. Metronidazole resistance and virulence factors in Helicobacter pylori as markers for treatment failure in a paediatric population
19. Influencia de la resistencia al metronidazol en la erradicación del Helicobacter pylori
20. Clarithromycin resistance in Helicobacter pylori as a marker for treatment failure in a pediatric population
21. Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori
22. The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies
23. Geographical distribution in the United States of primary resistance to clartithromycin and metronidazole in patients infected with Helicobacter pylori
24. Antibiotic resistance in Helicobacter pylori: Implications for therapy
25. Role of metronidazole resistance in therapy of H. pylori infection
26. Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori
27. Comparison of three methods for the determination of the sensitivity of H. pylori to metronidazole
28. Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents
29. Validation of a modified Kirby-Bauer disk diffusion method for metronidazole susceptibility testing of Helicobacter pylori
30. Antimicrobial resistance testing of Helicobacter pylori: A comparison of E-test and disk diffusion method
31. Discrepancies between E-test and agar dilution methods for testing metronidazole susceptibility of Helicopbacter pylori
32. Clarithromycin-resistant Helicobacter pylori patients with duodenal ulcer in the United States
33. Survey of the in vitro susceptibility of Helicobacter pylori to antibiotics in France. Preliminary results
34. Microbiological and serological diagnostic test for Helicopbacter pylori: An overview
35. Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in the Netherlands
36. Metronidazole and clarithromycin susceptibility amongst H. pylori clinical isolates from different Spanish regions
37. Helicobacter pylori resistance to macrolides increases, to imidazoles remains stable
38. No progression of primary metronidazole and clarithromycin resistance in clinical isolates of Helicobacter pylori Germany
39. Evolution of H. pylori primary resistance to antimicrobial agents in Belgium between 1995 and 1998
40. Surveillance of Helicobacter pylori resistance to antimicrobial agents in Belgium from 1989 to 1994
41. A nine years surveillance of H. pylori resistance to macrolides and imidazoles
42. Evolución de la resistencia antimicrobiana de Helicobacter pylori
43. Six years resistance of Helicobacter pylori to macrolides and imidazoles
44. Rapid increase in the prevalence of metronidazole-resistant Helicobacter pylori in the Netherlands
45. Six year follow-up of resistance to antibiotics of Helicobacter pylori in Bordeaux, France
46. ¿Utilizamos de forma razonada los macrólidos en atención primaria?
47. Tratamiento erradicador de Helicobacter pylori. Recomendaciones de la Conferencia Española de Consenso
48. Current European concepts in management of Helicobacter pylori infection. The Maastricht Consensus Report
49. The report of the Digestive Health Initiative International Update Conference on Helicobacter pylori
50. Cost of diagnosis and treatment of Helicobacter pylori: When does choosing the treatment regimen based on susceptibility testing become cost effective?
51. Non-endoscopic method to obtain Helicobacter pylori for culture
52. Clinical relevance of resistant strains of Helicobacter pylori: A review of current data
53. Primary and acquired. Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin - Influence of treatment outcome
54. Randomized trial of omeprazole and larithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains
55. Efficacy and optimum dose of omeprazole in a new 1-week therapy regimen to eradicate Helicobacter pylori
56. Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and timidazole to eradicate Helicobacter pylori
57. Comparison of two 1-week low-dose omeprazole thriple therapies - Optimal treatment for Helicobacter pylori infection
58. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: Does in vitro metronidazole resistance have any clinical relevance?
59. Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection: A short report
60. Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan
61. One-week triple therapy with lansoprazole, clartithromycin, and metronidazole to cure Helicobacter pylori infection in peptic ulcer disease in Korea
62. A prospective randomized trial comparing the use of omeprazole-based dual and triple therapy for eradication of Helicobacter pylori
63. One week triple therapy for Helicobacter pylori: A multicentre comparative study. Lansoprazole Helicobacter Study Group
64. A systematic review of Helicobacter pylori eradication therapy-the impact of antimicrobial resistance on eradication rates
65. Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance
66. An effective one-week Helicobacter pylori eradication therapy using omeprazole, clarithromycin and metronidazole
67. Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection
68. Standardisation of disk diffusion test and its clinical significance for susceptibility testing of metronidazole against H. pylori
69. Pretreatment antibiotic resistance in Helicobacter pylori infection: Results of three randomized controlled studies
70. Evaluation of short-term low dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized double-blind, controlled study
71. The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens. A meta-analysis